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Crossveinless 2 (CV-2) is an extracellular BMP mod-
ulator protein belonging to the Chordin family. During
development it is expressed at sites of high BMP
signaling and like Chordin CV-2 can either enhance
or inhibit BMP activity. CV-2 binds to BMP-2 via its
N-terminal Von Willebrand factor type C (VWC) do-
main 1. Here we report the structure of the complex
between CV-2 VWC1 and BMP-2. The tripartite
VWC1 binds BMP-2 only through a short N-terminal
segment, called clip, and subdomain (SD) 1. Muta-
tional analysis establishes that the clip segment
and SD1 together create high-affinity BMP-2 binding.
All four receptor-binding sites of BMP-2 are blocked
in the complex, demonstrating that VWC1 acts as
competitive inhibitor for all receptor types. In vivo ex-
periments reveal that the BMP-enhancing (pro-BMP)
activity of CV-2 is independent of BMP-2 binding by
VWC1, showing that pro- and anti-BMP activities
are structurally separated in CV-2.
INTRODUCTION
The Von Willebrand factor type C domain (VWC), which in the
literature is also often called Chordin-like CR domain, is one of
the most common protein modules, occurring—often several
times—in about 70 human proteins. The cellular role of most
VWCs is as yet unknown. For some VWCs existing in proteins
of the Chordin family, however, it has been established that
they bind bone morphogenetic proteins (BMPs) or TGF-bs and
thereby modulate their activity during development (Abreu
et al., 2002; Garcia Abreu et al., 2002; Larrain et al., 2000).
BMPs are a prominent group of extracellular signaling proteins
that regulate axis formation, tissue patterning, and organ devel-
opment during embryogenesis in all animals (De Robertis and
Kuroda, 2004; Hogan, 1996; Schier and Talbot, 2005). BMPs sig-
nal by assembling type I and type II serine/threonine kinase re-
ceptors in the cell membrane, which after transactivation releasephosphorylated Smad1/5/8 proteins into the nucleus to regulate
gene expression (Heldin et al., 1997; Miyazono et al., 2001). As
morphogens, BMPs form morphogenic fields and gradients,
where cells transform graded BMP signals into qualitatively
differing responses (O’Connor et al., 2006; Tabata and Takei,
2004). A plethora of proteins cooperate with BMPs in the extra-
cellular space (Canalis et al., 2003) in shaping these fields and
gradients by transporting BMPs and by inhibiting or stimulating
BMP signaling. Textbook examples are Noggin, Chordin, and
Follistatin, which are synthesized in the Spemann organizer or
its equivalent during gastrulation (De Robertis, 2006).
CV-2, a member of the Chordin family, was first identified as
a BMP modulator protein in Drosophila. When the cv-2 gene is
mutated, crossveins and tips of the long veins do not form.
During wing development CV-2 is concentrated, and signaling
initiated by DPP (the insect homolog of BMP-2/-4) becomes
increased in a narrow stripe at the positions of crossvein
formation (Conley et al., 2000). Remarkably, CV-2 expression
was found to be enhanced by Dpp signaling. On the basis of
these findings it was proposed that CV-2 and Dpp form a positive
feedback loop at locations where high Dpp signaling is required
(O’Connor et al., 2006). Later, CV-2 and positive BMP/CV-2
feedback loops were also found during development of mouse
(Coffinier et al., 2002; Ikeya et al., 2006), chicken (Coles et al.,
2004), and zebrafish (Rentzsch et al., 2006) in tissues and time
periods correlating with high BMP signaling. Thus, in vivo CV-2
can exert a pro-BMP activity, meaning that it can stimulate
BMP signaling. However, in certain developmental stages and,
in particular, during cell culture experiments, CV-2 can also
inhibit BMP signaling (Binnerts et al., 2004; Moser et al., 2003);
therefore, CV-2 can exhibit pro-BMP and anti-BMP activities
depending on the cellular context.
CV-2 contains five closely spaced VWC domains at its N-ter-
minal followed by a single von Willebrand factor type D (VWD)
and a trypsin inhibitor-like cysteine-rich (TIL) domain. Other
BMP modulator proteins of the Chordin family—e.g., Chordin,
Chordin-like 1, Chordin-like 2 (CHL2), Kielin (a CV-2 relative),
CCN1-6, and others (Canalis et al., 2003; Garcia Abreu et al.,
2002)—interact with BMPs via the VWC domains. Previous stud-
ies showed that Chordin, CHL2, and CV-2 use their VWC do-
mains to bind BMPs in different ways (De Robertis and Kuroda,Developmental Cell 14, 739–750, May 2008 ª2008 Elsevier Inc. 739
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Crystal Structure of the CV-2 VWC1:BMP-2 Complex2004; Zhang et al., 2007). BMP binds Chordin with a 1:1, and
CHL-2 and CV-2 with 1:2, stoichiometries. The VWC domain
can have contacts in the type I or in the type II receptor-binding
epitope of BMP or in both of them. CV-2 binds BMPs through its
first N-terminal VWC1 domain. Its affinity for BMP-2 is much
higher than those of VWCs in other Chordin-like proteins and
similar to that of the cooperative binding of two VWC domains
in full-length Chordin or the type I BMP receptor BMPR-IA
to BMP-2 (Zhang et al., 2007). However, the structural basis of
the interaction of BMP-2 and CV-2 or its VWC1 domain is as
yet unknown.
An NMR structure of the VWC domain of collagen IIA (Col IIA)
has been reported previously, which also showed the similarity
of the VWC domain to the fibronectin type I domain; however,
details about binding and recognition of cognate ligands could
not be shown (O’Leary et al., 2004). Here we report the structure
of a complex between a BMP and a VWC domain. The structure
determined for BMP-2 bound to the VWC1 domain of CV-2 pro-
vides new and interesting data, which in the future will augment
an understanding of the cooperation of BMP-2 and CV-2 during
animal development. The structural data together with a muta-
tional analysis demonstrate a binding mode for a BMP modulator
protein that clearly differs from the interaction of BMP-7 and
Noggin (Groppe et al., 2002) or Activin and Follistatin (Harrington
et al., 2006; Thompson et al., 2005). Thus they provide, to our
knowledge, a first paradigm of VWC structure and BMP binding
and are likely relevant for the 201 VWC domains present in about
70 other human proteins.
RESULTS
The Structure of the CV-2 VWC1 Is Tripartite
Previous experiments with zebrafish CV-2 showed that the high-
affinity binding of BMP-2 resides in the N-terminal VWC domain
(see Figure S1A available online). The four other VWC domains
2–5 and the C-terminal segment comprising the VWD and TIL
domains do not interact with BMP-2 (Zhang et al., 2007). The
amino acid sequence of the first CV-2 VWC domain is highly sim-
ilar in Drosophila, Xenopus, zebrafish, chicken, and man (Fig-
ure S1B). Compared to VWC domains of other proteins, which
also bind BMP-2 (but with significantly lower affinity), sequence
similarity is restricted mainly to the cysteine-consensus pattern
(Figure S1C). The structure of the VWC1 of zebrafish CV-2 com-
prising residues Leu1–Gly66 (equivalent to Leu4–Gly68 of the
human homolog) reveals an unusual modular architecture
when bound to BMP-2 (Figure 1A). The domain can be subdi-
vided into three parts, an N terminus (Leu1–Ser8), which we refer
to as the clip, an N-terminal subdomain SD1 (Cys9–Lys42), and
a C-terminal subdomain SD2 (Cys43–Gly66).
The clip exhibits an extended conformation with its C-terminal
end being fixed via a disulfide bond Cys9(I)-Cys31(IV) to subdo-
main SD1. SD1 has a three-stranded all-antiparallel b sheet, with
a very short irregular first strand b1 (Gly13–Val15), and the
second (Ile27–Cys31) and the third strand (Ala36–Gly44) form
a regular b sheet. Two disulfide bonds stabilize the fold of SD1:
the first, Cys9(I)-Cys31(IV), between the end of the clip and the
C-terminal end of b strand 2; the second, Cys29(III)-Cys38(V),
connecting strands 2 and 3. SD2 consists of even less secondary
structure, with only a short two-stranded antiparallel b sheet740 Developmental Cell 14, 739–750, May 2008 ª2008 Elsevier Inc.comprising residues Val53–Val54 (b4) and Lys63–Cys64 (b5).
Despite the lack of secondary structure, SD2 seems rather rigid,
possibly due to the two disulfide bonds, Cys43(VI)-Cys61(IX) and
Cys50(VII)-Cys64(X), that ‘‘crosslink’’ the long b3b4 loop (Gly44–
Val53) to the N- and C-terminal ends of b strand 5. Thereby
the long loop and the C terminus of the VWC1 domain are fixed
to rigid elements. An additional disulfide bond between Cys26(II)
and Cys60(VIII) conserved in VWC domains couples SD1 and
SD2 such that orientation between the two subdomains is
more fixed than would result from just the long irregular b3b4
loop.
The CV-2 VWC1 domain exhibits a rod-like structure with
overall dimensions of 50 A˚3 25 A˚. The b sheets of the VWC1 do-
main are arranged in one plane and are less than 20 A˚ thick,
clearly showing that the VWC domain has no hydrophobic core
and thus does not exhibit a globular structure like other modula-
tor proteins, for example, Noggin or Follistatin.
The Structure of the CV-2 VWC1 Shares Some
Similarities with the Fibronectin Type I Module
and the VWC of Collagen IIA
Subdomain SD1 of VWC1 adopts a similar fold as the tandem
repeat of fibronectin type I (FNI) modules IV and V in fibronectin
(Figures 1B and 1C) (Williams et al., 1994). This similarity be-
tween SD1 and the FN I module was first reported for the VWC
domain of collagen IIA (O’Leary et al., 2004). A superposition re-
veals that the first b strand is longer than in CV-2 VWC1. The FNI
counterpart of the clip of CV-2 VWC1 forms a two-stranded
b sheet. The module V of the FNI tandem repeat has the same
domain orientation as CV-2 SD2, though the FNI module pair
lacks the intermodule disulfide bond. However, contacts be-
tween the FNI N terminus of the second module and the b2b3
loop of the first module might stabilize the module orientation.
Despite the similar subdomain orientation, SD2 of CV-2 VWC1
has no further similarities to the fibronectin FNI module or to
other known structural domains due to its low secondary struc-
ture content and irregular loop conformations.
Contrary to the VWC domain of Col type IIA (O’Leary et al.,
2004), which was shown to exist in two conformations with
regard to the orientation of the two subdomains (Figure 1D;
Figure S2), CV-2 VWC1 exhibits a single conformation in both
molecules in the asymmetric unit. Further differences between
the two VWC domain structures of CV-2 and Col IIA SD1 are
in the details of the clip and SD1 structure (Figures 1B and 1D).
The Col IIA VWC N terminus forms a two-stranded b sheet similar
to FNI, whereas the N terminus of CV-2 VWC1 is extended (Fig-
ures 1B and 1D). In addition, the b strand 1 of CV-2 VWC1 is short
followed by a bulged loop; however, in Col IIA VWC the first
strand is longer but regular.
The N-Terminal Clip of CV-2 VWC1 Blocks
the Type I Receptor-Binding Site of BMP-2
The CV-2 VWC1 binds BMP-2 on top of finger 2, overlapping
with the so-called knuckle epitope identified for type II receptor
interaction (Figures 2A and 2B). Thus the complex consists of
BMP-2 with two VWC1 domains attached as was previously pro-
posed by biochemical evidence (Zhang et al., 2007). This study
also revealed that CV-2 VWC1 is capable of simultaneously in-
hibiting types I and II receptor binding. Structure analysis shows
Developmental Cell
Crystal Structure of the CV-2 VWC1:BMP-2 ComplexFigure 1. Structure of the VWC Domain 1 of Crossveinless 2
(A) Stereoview of CV-2 VWC1 from the complex BMP-2:CV-2 VWC1. The clip is shown in cyan; SD1 is indicated in red, SD2 is marked in green. Secondary struc-
ture elements and N- and C termini are highlighted. The disulfide bonds are shown as sticks.
(B–D) A comparison of the structures of the VWC domains of CV-2 (B) and Col IIA ([D], pdb entry 1U5M) and the FNI domain pair 4 and 5 of fibronectin ([C], pdb
entry 1FBR) is shown. Cysteine pairing is shown by roman numerals.that the architecture of the CV-2 VWC1:BMP-2 interaction
is quite unexpected and has several unusual features. The clip
extends from subdomain SD1, reaching into the wrist epitope
of BMP-2. The interaction of the relatively flat VWC1 domain of
CV-2 with subdomains SD1 and SD2 sticking on the knuckle
epitope and the clip in the wrist epitope almost reminds one of
a paperclip holding a paper sheet (BMP-2) (Figures 2A and 2C).
The N terminus Leu1–Glu6 fits snugly into the cleft formed
by helix 1 of one BMP-2 monomer and the b sheet of fingers 1
and 2 of the other BMP-2 monomer. Hereby it covers most of
the hydrophobic patch of the wrist epitope required for type I
receptor binding (Figure 3A). It seems surprising how a short
flexible peptide could bind strongly and consequently compete
for the high-affinity interaction of the type I receptors.
Several features observed in the structure of the complex
could explain the inhibitory properties of the clip.
First, five hydrogen bonds are formed between the clip
and BMP-2, all of which involve only main-chain atoms of the
VWC1 clip (Figure 3A, Table S1). Three of the five H bondsDemploy main-chain groups also on BMP-2. This possibly has
two consequences: The clip requires almost no sequence con-
servation, as no side chain function is involved in binding and
recognition. Furthermore, by using mostly main-chain groups
for the H bond network, binding is highly cooperative and thus
stabilizes the complex.
Second, similar to the knob-into-hole interaction in BMP-
2:BMPR-IA (Kirsch et al., 2000b), where Phe85 of BMPR-IA
points into the hydrophobic pocket in BMP-2 formed by Trp28,
Met89, Tyr103, Met106, and Ile62 (Figure 4A), Ile2 of CV-2
VWC1 is pointing into the same cleft, thereby burying most of
its surface (Figure 4B). Interestingly, in CV-2 VWC1 a hydropho-
bic residue type, either Ile or Leu, is strictly conserved between
different species at this position (Figure S1B), highlighting its
importance for this interaction.
Third, besides Ile2, the adjacent two amino acids also seem to
be highly conserved. Whereas for Thr3 no requirements seem to
exist, a glycine at the position 4 is strictly necessary (Figure 3A).
This is not due to a special backbone torsion angle constraint butevelopmental Cell 14, 739–750, May 2008 ª2008 Elsevier Inc. 741
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Crystal Structure of the CV-2 VWC1:BMP-2 ComplexFigure 2. CV-2 VWC1 Binds to BMP-2 Like a Paperclip
(A) Ribbon representation of the complex of CV-2 VWC1:BMP-2. Monomer subunits of BMP-2 are shown in blue and yellow.
(B) As in (A) but shown from above; wrist and knuckle epitopes of BMP-2 are indicated.
(C) The VWC1 domain of CV-2 binds to BMP-2 like a paperclip, with SD1 (red) hooked onto the knuckle epitope of BMP-2 and the clip (cyan) folding over into the
wrist epitope.due to the fact that the side chain at position 4 points toward the
BMP-2 surface; thus, any amino acid different from a glycine
would impede binding of the VWC domain clip.
SD1 of CV-2 VWC1 Binds to the Knuckle Epitope
of BMP-2
Subdomain SD1 seems to provide the bulk of the interaction
for BMP-2 inhibition (Figures 3B and 3C); it is thus remarkable
that the buried surface area (total is 877 A˚2 for CV-2 VWC1)
contributed by SD1 is smaller (buried surface area is 365 A˚2
for Ala7–Gly66) than that of the clip (512 A˚2 buried). Several
other features of this interface are remarkable. The SD1-BMP-2
epitope is dominated by hydrophobic interactions, with almost
70% contributed by hydrophobic residues. On CV-2 VWC1
these residues cluster in the b1b2 loop (Ile18–Ile21) and
b strands 2 (Ile27–Cys29) and 3 (Ala36–Glu40). The CV-2
VWC1-BMP-2 core interface has the disulfide bond Cys29-
Cys38 in the center of the interface of SD1 (Figure 3C), but oth-
erwise only a few side chains of the SD1 subdomain are in
direct contact with BMP-2 (Table S2). Taking as granted that
the BMP-binding epitope of other VWC domains has a similar
architecture, the small hydrophobic interface could mean that
the contact residues do not have to be highly conserved
among different VWCs as long as the hydrophobic character
and complementarity to the BMP interface are maintained.
This might also explain why we see so little sequence conser-
vation besides the cysteine consensus pattern among VWCs
from Chordin family members.
In total, only 12 residues of the CV-2 VWC1 SD1 are in contact
with the BMP-2 surface, raising the question of whether such
a small interface is sufficient for expelling all water molecules.
However, no electron density for buried water molecules can742 Developmental Cell 14, 739–750, May 2008 ª2008 Elsevier Inc.be observed within the SD1 core interface, showing that water
molecules play no role in binding or recognition. Thus, packing
is tight and geometric complementarity is high at the contact.
In comparison to the BMP-2 type II receptor interaction where
the b sheets of the ActR-IIB receptor run parallel to the BMP-2
b sheets of fingers 1 and 2 (Figure 4C), the three-stranded b sheet
of CV-2 VWC1 runs perpendicular to the BMP-2 b sheet (Fig-
ure 4D). The longer b sheets of the ActR-IIB ectodomain cover
a contact area twice as large, but affinity of ActR-IIB to BMP-2
is nevertheless rather low (KD = 2.7 mM for the 1:1 interaction;
Weber et al., 2007). Thus, it is interesting how high-affinity bind-
ing to BMP-2 is achieved for CV-2 VWC1.
The binding epitope of BMP-2 for CV-2 is compact; Leu100 of
BMP-2 is completely buried by residues Ala7, Ile18, Ile21, and
Ala36 of CV-2 VWC1. Other hydrophobic residues of BMP-2,
Val33, Ala34, Pro35, Val98, Val99, and Leu90, also found to be
important for type II receptor binding, contribute significantly to
the interface for CV-2 as well. Residue Ser88 of BMP-2, being
central in the BMP-2:ActR-IIB interaction, however, is on the
periphery of the CV-2 VWC1:BMP-2 interface, showing that
the center of the interface is shifted toward the fingertips of
BMP-2. It is remarkable that there is not a single intermolecular
polar bond between SD1 and BMP-2, clearly showing that the
interaction in the knuckle epitope of BMP-2 depends solely on
hydrophobic forces.
In summary, the SD1 subdomain of CV-2 VWC1 occupies
a major part of the type II receptor binding site and thus blocks
type II receptor binding to BMP-2. The clip itself blocks type I
receptors from binding to BMP-2. From their small size it seems
likely that both elements, the clip and SD1, of CV-2 VWC1 will
bind only weakly alone (see below), but linked together they
generate high-affinity binding via strong cooperativity.
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Crystal Structure of the CV-2 VWC1:BMP-2 ComplexSD2 Shares No Contact with BMP-2
The structure of CV-2 VWC1:BMP-2 reveals that the 24 residue
SD2 has no contact with the knuckle epitope of BMP-2, suggest-
ing that it can be removed without altering binding affinity (see
below). In the NMR structure of Col IIA VWC, SD2 and SD1,
which are connected via the peptide chain and a disulfide
bond between Cys(II) and Cys(VIII), show a variable orientation
to each other (O’Leary et al., 2004) (Figure S2). Since in X-ray
analysis the result is only a single structure and not a structure
ensemble, analysis of conformational variability is normally lim-
ited. However, in our crystal the full complex comprising two
CV-2 VWC1 molecules is in the asymmetric unit. We therefore
compared the SD1-SD2 subdomain orientation of both VWC1
molecules, which is identical, suggesting a rigid structure with
defined subdomain orientation. This rigid and defined interdo-
main SD-SD2 orientation in the VWC1 of CV-2—in contrast to
the very flexible hinge angle in Col IIA VWC—can be explained
by stabilizing crystal lattice contacts (Figure S3). The b strand
4 (residues Ala51–Val54) in SD2 of CV-2 VWC1 forms three inter-
molecular H bonds with a symmetry-related BMP-2 molecule.
To exclude the possibility that these crystal lattice contacts
distort the CV-2 VWC1 domain in such a way that SD2 is unable
to contact the knuckle epitope of BMP-2, we superimposed the
NMR structure ensemble of Col IIA VWC (Figure S2) and the
structure of CV-2 VWC1. However, no structure of the NMR en-
semble exhibits a conformation that would shift SD2 closer to the
knuckle epitope of BMP-2 as seen for the CV-2 VWC1:BMP-2
complex. This suggests that SD2—despite being conserved
Figure 3. Interactions between the Wrist
and Knuckle Epitopes of BMP-2 and CV-2
VWC1
(A) H bond network (dashed lines) formed between
the clip of CV-2 VWC1 and BMP-2 (stereoview).
(B) Binding epitope of BMP-2 to CV-2 VWC1 sub-
domain SD1. Hydrophobic amino acids are gray,
negatively charged residues are red, positively
charged residues are blue, and polar residues
are green. Darker colors mark the area buried
from solvent upon binding to CV-2 VWC1.
(C) As in (B) but for CV-2 VWC1. Only SD1 and SD2
of VWC1 are shown for better visualization of the
contacts in the knuckle epitope.
among BMP-binding VWC domains—is
not required for the direct interaction of
CV-2 VWC1 and BMP-2. It is conceivable,
however, that in the context of the whole
CV-2 protein, subdomain SD2 might indi-
rectly modulate BMP-activity.
The N-Terminal Clip Plus SD1 Is
Sufficient for BMP-2 Binding
The CV-2 VWC1:BMP-2 complex struc-
ture suggests that SD1 and possibly the
clip alone account for the high-affinity
binding between the proteins. The contri-
bution of the clip to BMP-2 binding was
evaluated by two CV-2 VWC1 truncation
variants lacking the residues Leu1–Thr5
(LITGT) or Leu1–Ala7 (LITGTEA). The two variants, VWC1Dclip1
and VWC1Dclip2, exhibited a 100- and 2000-fold lower affinity
for BMP-2 (Table 1). This corresponds to the loss of affinity ob-
served with point mutations in the clip segment (see below).
Thus, the clip contributes significantly to high-affinity binding
to BMP-2.
To test the above-mentioned hypothesis that, in contrast to
the clip, SD2 of CV-2 VWC1 does not contribute to binding of
BMP-2, we constructed a truncation variant VWC1DSD2, which
lacks the complete C-terminal subdomain from residue Cys43
and contains a serine at the position of Cys26, the latter of which
is involved in the SD1/SD2 disulfide bond. The variant can be iso-
lated and binds BMP-2 with wild-type-like affinity (Table 1). In
summary, our results clearly prove that high-affinity binding of
VWC1 to BMP-2 requires only the clip and SD1 as a minimal in-
hibitory domain. The interaction of SD1 with the knuckle epitope
of BMP-2 delivers only low-affinity binding similar to the type
II receptor-BMP-2 interaction. The presence of the clip region
then shifts the binding affinity for BMP-2 to a low nanomolar
value.
H Bonds Are Crucial for Clip Binding,
whereas Hydrophobic Interactions Dominate
the SD1:BMP-2 Interaction
Since the VWC1 clip interacts with BMP-2 via several H bonds
that are located on the solvent-accessible surface, an additional
stabilization of these polar interactions seems necessary for
a stable interaction. We therefore tested the knob-into-holeDevelopmental Cell 14, 739–750, May 2008 ª2008 Elsevier Inc. 743
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Crystal Structure of the CV-2 VWC1:BMP-2 ComplexFigure 4. CV-2 VWC1 Binds to BMP-2, Thereby Blocking Type I and Type II Receptor Binding
(A) The type I receptor-binding epitope is shown for BMPR-IA (brown; pdb entry 2H62) and BMP-2 (surface representation, color-coding as in Figures 3D and 3E).
The darker colors indicate the area occupied by the type I receptor. A comparison with the area occupied by the clip of CV-2 VWC1 (B) shows that both binding
sites overlap. (C) Comparison of the type II receptor-binding epitope (shown for the ActR-IIB:BMP-2 interaction; pdb entry 2H62) and the area occupied by SD1 of
CV-2 VWC1 (D). As for type I receptor binding, the type II receptor and CV-2 VWC1 binding epitopes overlap in the knuckle epitope, with the binding area of CV-2
VWC1 being much smaller.motif, which involves Ile2 on CV-2 VWC1 as a possible candidate
(Figure 4B). The variant I2A binds BMP-2 with 6-fold lower affinity
(Table 1), confirming its role in stabilizing the binding of the clip to
BMP-2. Mutation of Phe85 to alanine in BMPR-IA, which is a sim-
ilar knob-into-hole motif for the BMP-type I receptor interaction,
also resulted in a significant reduction in affinity to BMP-2 (Hatta
et al., 2000).
To evaluate the contribution of the intermolecular polar bonds
involving main-chain groups, we employed proline mutagenesis.
Exchange of an amino acid with proline removes the main-chain
amide proton, which is possibly involved in an H bond, and
thereby destroys this polar bond (Keller et al., 2004). All proline
variants of VWC1 compiled in Table 1 could be prepared and pu-
rified similar to wild-type VWC1. The H bond involving the VWC1
Thr3 amide and the BMP-2 Asn59 carboxamide contributes only
marginally, with a reduction in binding affinity of only 2.5-fold in
the T3P variant. In contrast, the three main-chain–main-chain
polar bonds (two for VWC1-Thr5/BMP-2-Asn102 and one for744 Developmental Cell 14, 739–750, May 2008 ª2008 Elsevier Inc.VWC1-Ala7/BMP-2-Leu100) at the edge of BMP-2 finger 2 are
crucial for the interaction. The VWC1 variant T5P binds BMP-2
with 20-fold lower affinity. The contribution of the H bond be-
tween the CV-2 VWC1 Ala7 amide and BMP-2 Leu100 carbonyl
can be estimated from the 20-fold difference in the binding affin-
ities of the two CV-2 VWC1 truncation variants VWC1Dclip1 and
VWC1Dclip2, whose interaction only differs in this H bond.
The results reveal that the large reduction in affinity upon trun-
cation of the N terminus can be associated mainly with three
interaction pairs: the hydrophobic knob-into-hole interaction
provided by VWC1 Ile2 and the H bonds formed between the
main-chain groups of VWC1-Thr5:BMP-2-Asn102 and VWC1-
Ala7:BMP-2-Leu100. The other interactions seem to be energet-
ically silent.
The VWC1 SD1 interacts with the knuckle epitope of BMP-2
via hydrophobic interactions. A large part of the interface is pro-
vided by the disulfide bond between VWC1 Cys29 and Cys38,
which is not amenable to mutagenesis without destruction of
Developmental Cell
Crystal Structure of the CV-2 VWC1:BMP-2 Complexstructural integrity. Several other hydrophobic residues contrib-
ute to the interaction in the knuckle epitope either via direct con-
tacts or by solvent shielding. Mutagenesis shows that several
of these residues contribute significantly to the binding affinity.
Upon mutation of Ile21 or Ile27 to Ala, about 1.3 kcal mol1 of
binding free energy is lost. More disruptive mutations, e.g.,
I21R and A36R, show that packing in spite of the small interface
is quite tight. However, in comparison to the functional epitope of
the BMP-2:ActR-IIB contact, a similar hydrophobic hot spot of
binding like Trp60 or Tyr42 of ActR-IIB (Weber et al., 2007)
seems not to exist.
Anti-BMP Activity of CV-2 In Vivo Is Confined
to the VWC1 Domain
CV-2 VWC1 functions as an inhibitor in a BMP-2-induced alka-
line phosphatase (ALP) assay. The activity of 10 nM BMP-2
was inhibited by VWC1 in a dose-dependent manner with a
half-maximal concentration (IC50) of 50 nM (Figure 5A). The trun-
cation variant VWC1DSD2 was also an efficient inhibitor, but the
IC50 was increased 4-fold, even though variant and wild-type
VWC1 bind immobilized BMP-2 with the same affinity in vitro (Ta-
ble 1). It remains to be determined whether the missing SD2 ex-
erts additional steric hindrance for type II receptors, thereby en-
hancing inhibition, or whether the shortened CV-2 VWC1DSD2 is
Table 1. Binding of CV-2 VWC1 Variants to Immobilized BMP-2:
Biacore Analysis
KD (eq)
a
(nM)
kon 3 10
6
(M1s1)
koff 3 10
2
(s1)
KD (koff/
kon) (nM)
KD (var)/KD
(wild-type)
Truncation variants
VWC1long
b — 1.4 2.6 22 1.0
VWC1c — 1.2 2.4 20 1.0
VWC1DSD2d — 1.2 4.0 33 1.5
VWC1Dclip1e 2,700 0.012g 3.2 — 135
VWC1Dclip2f 48,000 0.0005g 2.4 — 2,400
Single point mutations
L1A — 1.3 2.8 22 1.0
L1R — 1.2 2.8 23 1.0
I2A 127 — — — 6.4
I2R 66 — — — 3.3
T3P — 0.95 4.8 50 2.5
T5P 417 0.18g 7.5 — 21
I18A — 0.88 4.4 50 2.5
I18R — 2.0 8.9 45 2.3
I21A 200 — — — 10
I21R 790 — — — 40
I27A 185 — — — 9.3
I27R 160 — — — 8.0
A36R 227 — — — 11
a Affinities from dose dependency of equilibrium binding.
b VWC1long: GSGAMATPQSTAPLITGTEAS.G66.
c VWC1: GSWLITGTEAS.G66.
d VWC1DSD2: GSWLITGTEAS.C26S.K42.
e VWC1Dclip1: GSEAS.G66.
f VWC1Dclip2: GS.G66.
g Calculated from kon = koff/KD (eq).Ddegraded or inactivated during the time required for the ALP as-
say. Some VWC1 mutants with reduced binding affinity, such as
T5P, I21A, and I2A, exhibited a lower inhibitory effect. Other mu-
tants with more strongly reduced affinity, notably VWC1Dclip1 or
I21R, did not inhibit biological activity up to a 1 mM concentration.
For all mutants that have been analyzed, the inhibitory potency
seems to be not strictly correlated with BMP-2 binding affinity.
Neither the wild-type VWC1 nor the mutants exhibited a stim-
ulatory effect on BMP activity at any of the concentrations exam-
ined (Figure 5A). In contrast, such a stimulatory effect or pro-
BMP activity has been reported for the complete CV-2 protein
in cell-based assays (Kamimura et al., 2004) and in vivo (Coles
et al., 2004; Ikeya et al., 2006; Rentzsch et al., 2006). This
suggests that the isolated VWC1 domain is not sufficient for
pro-BMP activity and that, in addition, other proteins or CV-2
domains are necessary for this activity.
To test the effect of mutations in the VWC1 domain in vivo, we
performed mRNA injection experiments in zebrafish embryos
showing that—consistent with previous experiments (Rentzsch
et al., 2006)—overexpression of wild-type CV-2 led to moderate
dorsalization or weak ventralization of the embryos (Figures 5C
and 5D). In contrast, injection of the mRNA of cv-2-CM, a mutant
that is not processed at an internal Asp-Pro site in vivo, caused
strong dorsalization (Figure 5F). Injection of mRNA of the BMP-2
binding-deficient mutant cv-2-WT-I21R resulted in weakly ven-
tralized embryos (Figures 5E and 5I). This suggests that the
BMP-2-antagonizing properties of CV-2 VWC1 correspond to
the anti-BMP activity in the context of the whole CV-2 protein.
When we additionally introduced the mutation I21R, which
strongly attenuates BMP-2 binding of VWC1, into cv-2-CM, a
full rescue from dorsalization could be observed (Figures 5G–
5I). Thus, the BMP binding of VWC1 seems to be solely respon-
sible for the anti-BMP activity of overexpressed CV-2 in vivo,
whereas the weak ventralizing activity (pro-BMP activity) of
CV-2 WT is very likely to be independent of BMP binding. One
important conclusion of the in vivo experiments in zebrafish is
therefore that the two contrary anti- and pro-BMP activities
can be structurally separated to different regions/domains of
the full-length CV-2.
DISCUSSION
In this study we present the structure of a VWC domain of a BMP
modulator of the Chordin family in complex with its cognate li-
gand BMP-2. The VWC domain 1 of CV-2 shows several new
and unexpected features. Although it has a small size of only
66 residues, it exhibits a tripartite architecture resembling a pa-
perclip. For binding of CV-2 to BMP-2, only the N-terminal clip
and the first of the two subdomains of VWC1 are required.
Thus, the parts necessary for high-affinity interaction are just
42 amino acids long but nevertheless capable of interacting
with BMP with nanomolar affinity, similar to BMP receptors or
modulator proteins several times this size.
An extended SD1/SD2 subdomain architecture with only little
secondary structure is likely a common property of the many
VWC domains known. Most of the stabilization of the VWC fold
arises from 10 conserved cysteines forming a compact disulfide
network in the 66 residue protein. The idea that corresponding
subdomains SD1 and SD2 are present in all VWC domains isevelopmental Cell 14, 739–750, May 2008 ª2008 Elsevier Inc. 745
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(A) The inhibition efficiency of ALP expression induced by 10 nM BMP-2 in C2C12 cells was determined by increasing doses of CV-2 VWC1 and variants thereof.
Errors bars show the standard deviation from three independent experiments.
(B–I) Phenotypes of zebrafish embryos after mRNA injections. (B–G) Lateral views of 32 hpf embryos; arrows indicate dorsalized traits (loss of ventral tail fin/tail);
arrowheads indicate ventralized traits (smaller head, expansion of ventral-most tissues). Injection of cv-2-WT mRNA leads to both weakly dorsalized (C1 in [C]) or
weakly ventralized (V1 in [D]) embryos, whereas injection of cleavage-resistant construct cv-2-CM mRNA causes strong dorsalization (C3 in [F]). Injections of
mRNA of the mutants cv-2-WT-I21R or cv-2-CM-I21R result in weakly ventralized (E) or normal (G) embryos similar to those in (D) and (B), respectively. (H) Graph-
ical illustration of proportions of phenotypes generated on injection of different CV-2 constructs. For classification C5 (strong dorsalization) to V2 (strong ventral-
ization) see Rentzsch et al. (2006). Numbers of analyzed embryos are indicated above the columns. (I) In situ hybridization of whole-mount 80% epiboly-stage
embryos; animal pole views; dorsal, right. Arrows indicate the limits of dorso-lateral mesoderm marker tbx24 (dark blue), which is expanded in dorsalized and
reduced in ventralized embryos.further substantiated by the NMR structure of the Col IIA VWC
domain, which established the SD1/SD2 architecture and also
a similarity of SD1 to the FNI domain for the first time (O’Leary
et al., 2004). However, not all VWC domains share a tripartite
structure with a functionally important N-terminal clip. In several
proteins tandem repeats of VWC modules are connected via
only 2–3 residues between the last cysteine of one VWC and
the first cysteine of the following repeat. The clip of CV-2
VWC1 appears to be rather unusual and is highly conserved in
CV-2 from vertebrates to nonvertebrates (Figure S1B), but it
seems to be absent in BMP-2-binding VWC domains, such as
those from Chordin, CHL2, or Col IIA (Figure S1C).
The functional epitope in subdomain SD1 of CV-2 VWC1 is
central in BMP binding, since VWC1 retains appreciable BMP-
binding affinity even after complete or partial truncation of the
clip segment. The present structural and mutational analysis
revealed that this epitope contains in its core the Cys29-Cys38
disulfide bond and the side chain of Ile21, both exposing large
hydrophobic surfaces. The disulfide bond as part of the cysteine
consensus pattern as well as large hydrophobic side chains
(mostly tryptophane) at a position corresponding to Ile21 are
among the few elements that are conserved in all VWC domains
of the Chordin family members and even in the FNI domains, for
instance, in fibronectin. It leads to, therefore, an exciting idea
that all VWC or even FNI domains have the potential to form
a BMP-binding epitope around these key determinants (‘‘hot
spots’’). Side chains surrounding this hot spot differ vastly
among the domains and therefore might be secondary determi-746 Developmental Cell 14, 739–750, May 2008 ª2008 Elsevier Inc.nants that enforce, weaken, or even prevent the binding of TGF-
b-like proteins (for a more detailed discussion see Supplemental
Data, Table S2).
The BMP-binding mode of another VWC domain, Col IIA VWC,
whose structure has been determined by NMR (O’Leary et al.,
2004) is as yet unknown. Assuming the same binding interface
for both VWC domains, BMP-2 could bind only after a major re-
arrangement of the Col IIA VWC protein, as the epitope on Col IIA
VWC is largely inaccessible in its current structure (Figure S4).
Indeed, no interaction with BMP-2 could be determined with
the construct used for NMR structure determination (K. Downing
and W.S., unpublished data); however, full-length Col IIA never-
theless binds BMP-2 in vivo and in vitro (Larrain et al., 2000; Zhu
et al., 1999). These observations suggest that the intrinsic BMP
affinity of a single Col IIA VWC is low. Only when multiple VWC
domains cooperate, as seems to happen in collagen triple heli-
ces in the extracellular matrix, is a functionally relevant affinity
for BMP generated by avidity effects (Larrain et al., 2000;
O’Leary et al., 2004). An enhancement of binding affinity via
multiple weak cooperative interactions therefore seems to be
a general mechanism by which VWC-domain containing proteins
interact with BMPs and TGF-bs. CV-2 VWC1 has evolved a
mechanism by which binding affinity for BMP-2 is increased
through an ‘‘internal’’ cooperativity employing two-epitope bind-
ing via the clip and SD1 subdomain. Other VWC-containing
modulator proteins like Chordin generate high-affinity BMP bind-
ing through cooperation of two VWC domains. Thus, cooperativ-
ity effects seem always to be required, probably due to the
Developmental Cell
Crystal Structure of the CV-2 VWC1:BMP-2 ComplexFigure 6. Comparison of the Inhibition Modes of Different BMP Modulator-BMP Complexes
(A) CV-2 VWC1 binding to BMP-2 (blue/yellow) blocks the type I and II receptor epitopes (color code as in Figure 2).
(B) Both receptor sites are blocked by Noggin binding to BMP-7. The part of Noggin marked in red represents the topological equivalent of the CV-2 SD1 sub-
domain in (A). An N-terminal clip (cyan) similar to CV-2 VWC1 inhibits type I receptor binding.
(C) Follistatin binding to Act-A also blocks the type I and II receptor epitopes; the two subdomains FSD1 and FSD2 (indicated in red) block the type II receptor-
binding site. Contrary to CV-2 and Noggin, the type I receptor epitope is blocked by the globular N-terminal domain of Follistatin (brown and cyan).
(D–F) As in (A)–(C) but shown from the top.limited binding affinity linked to the small domain size of SD1;
however, the route by which it is generated varies.
The binding and receptor blocking mechanisms of Noggin,
Follistatin, and CV-2 share some clear analogies, although their
overall structures are completely unrelated (Groppe et al.,
2002; Harrington et al., 2006; Thompson et al., 2005). Noggin,
Follistatin, and CV-2 VWC1 differ vastly in size and architecture
(Figure 6), but all three modulator proteins and domains seem
to interact with the ligand mainly via the type II receptor binding
epitope. About 730 A˚2 of surface area per molecule is buried in
the knuckle epitope upon binding of Noggin to BMP-7, twice
as much compared to the VWC1 SD1 binding to BMP-2. For Fol-
listatin the complete type II receptor-binding site of Activin-A
(Act-A) is covered by the domains FSD1 and FSD2 burying about
820 A˚2 per molecule in the knuckle epitope.
Additionally, all structurally known modulator proteins block
not only the type II receptor epitope but also the type I receptor
epitope. The N-terminal domain of Follistatin binds in the wrist
epitope of Activin-A, thereby inhibiting type I receptor binding
(Thompson et al., 2005). However, binding of Follistatin to
BMPs might be different, as type I receptors and Follistatin
were reported to bind simultaneously to BMP-4 (Iemura et al.,
1998) (for detailed discussion, see Thompson et al., 2005). In
the case of Noggin, a clip similar to CV-2 VWC1 folds over finger
2 and binds in the BMP wrist (type I receptor) epitope (Groppe
et al., 2002). The backbone Pro35–Ser38 of Noggin superim-
poses almost perfectly on the backbone of the corresponding
residues Ile2–Thr5 in the clip of CV-2 VWC1. Pro35 of Noggin
makes a similar knob-into-hole interaction with BMP-7 as Ile2
of CV-2 VWC1 with BMP-2. Noggin Ala36 and Ser38 form Hbonds to Asn83 and Lys127 of BMP-7, similar to those of Thr3
and Thr5 of the VWC1 clip in the interaction with BMP-2. Muta-
genesis showed that substitution of Pro35 by Arg leads to 7-fold
lower affinity for BMP-7 (Groppe et al., 2002). Furthermore, famil-
iar Symphalangism (Mangino et al., 2002) results from the het-
erozygous mutation P35S, confirming the importance of the N
terminus of Noggin in vivo.
CV-2 is a bifunctional protein in vivo that can inhibit and stim-
ulate BMP signaling. The affinity for BMP-2 is the same in (1) wild-
type CV-2, which is processed in vivo to unknown extent, (2) in an
uncleavable mutant CV-2-CM, and (3) in the isolated VWC1 do-
main of CV-2 (Rentzsch et al., 2006; Zhang et al., 2007). Thus, at
sufficiently high levels, all three forms can inhibit BMP signaling.
The potency of this anti-BMP activity in vivo, however, differs in
wild-type CV-2 and CV-2-CM, possibly due to avidity effects.
The zebrafish CV-2-CM variant binds efficiently to proteoglycans
in the extracellular matrix or the cell surface, whereas the cleaved
CV-2 WT binds considerably more weakly. As a consequence,
uncleaved CV-2 anchored by proteoglycans can act as a type
of BMP ‘‘pseudoreceptor,’’ where two coupled CV-2 molecules
bind BMP-2 with higher affinity. Measurements in vitro mimicking
a CV-2 ‘‘coupling’’ in a Biacore setup have confirmed such an af-
finity enhancement. In line with these considerations, the CV-2-
CM mutant exhibits no pro-BMP in vivo but an increased anti-
BMP activity compared to wild-type CV-2, which is expected
for a proteoglycan-bound CV-2 with a higher BMP-2 affinity
than cleaved soluble wild-type CV-2. CV-2-CM likely represents
a correlate of the unprocessed wild-type CV-2 in vivo. It remains
to be established if the uncleaved wild-type CV-2 functions
in vivo, and where and at what stage the protein is processed.Developmental Cell 14, 739–750, May 2008 ª2008 Elsevier Inc. 747
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Crystal Structure of the CV-2 VWC1:BMP-2 ComplexTable 2. Processing and Refinement Statistics for the MAD Dataset for the Complex Se-Met BMP-2(F41M;Y91M):CV-2 VWC1
Crystal BMP-2(F41M;Y91M):CV-2 VWC1
Space group I41
Cell constants a = b = 83.74 A˚, c = 139.84 A˚; a = b = g = 90
Se-Met (l1) Se-Met (l2) Se-Met (l3)
Wavelength 0.9799 A˚ 0.9796 A˚ 0.9079 A˚
Resolution (A˚)a 36.2–2.70 A˚ (2.80–2.70 A˚) 40.7–2.70 A˚ (2.80–2.70 A˚) 36.2–2.70 A˚ (2.80–2.70 A˚)
l1 (inflection) l2 (peak) l3 (remote high)
Number of measured reflectionsb 43,616 (4,242) 43,563 (4,292) 43,969 (4,311)
Number of unique reflectionsb 13,191 (1,303) 13,146 (1,305) 13,165 (1,308)
Completeness 99.7 (99.7) 99.7 (99.8) 99.7 (100.0)
Multiplicity 3.3 (3.2) 3.3 (3.3) 3.3 (3.3)
Rsym for all reflections
c 9.0 (34.2%) 10.0 (34.2%) 9.9 (38.1%)
<Intensity/s> 8.9 (3.3) 7.7 (3.1) 8.0 (2.7)
Phasing 7 out of 8 Se sites identified
Rcullis
d 0.840 0.719 0.835
Rms lack-of-closuree 0.763 0.917 0.753
Phasing powerf 1.01 1.38 1.09
Figure of merit after DM 0.74
Refinement Statistics
Resolution 40.0–2.70 A˚ (2.77–2.70 A˚)
Rcryst 20.3 (29.0%)
Rfree (test set 5%) 24.5 (35.9%)
Rms deviation
Bonds 0.013 A˚
Angles 1.603
Torsion angles 6.829
Average B Factor 56.2 A˚2
Crossvalidated sigma coordinate error 0.31 A˚
Solvent content 62.7%
Procheck analysis
Residues in most favored region 84.9% (253)
Residues in additional allowed region 13.4% (40)
Residues in generously allowed region 1.0% (3)
Residues in disallowed region 0.7% (2)
a Number in parentheses indicate highest resolution shell.
b Cut-off for reflections F > 0s.
c Rsym =
P
hkljIhkl  <Ihkl>j/
P
hkl<Ihkl> where <Ihkl> is the mean intensity of symmetry related observations of a unique reflection.
d Rcullis = <phase-integrated lack of closure>/<FPH – FP>.
e Root-mean-square of lack-of-closure normalized O32 =
P j(jFP+FHj)2  jFPHj2).
f Phasing power = (OjFH2j)/(Ojlack-of-closure2j), calculated for anomalous contribution.The present study with zebrafish embryos showed that a mu-
tant CV-2 with 40-fold decreased BMP affinity lost anti-BMP ac-
tivity, but still enhanced BMP signaling (Figures 5E, 5H, and 5I).
Thus, surprisingly, the pro-BMP activity of CV-2 seems to be
independent of its high-affinity interaction with BMP, suggesting
that the two opposing functions—pro- and anti-BMP activity—
are structurally separated in the CV-2 protein. These observa-
tions open the possibility that CV-2 shares functional similarities
with twisted gastrulation (Tsg). Tsg also displays pro- and anti-
BMP activity in vivo (De Robertis and Kuroda, 2004), and the
pro-BMP activity of Tsg is independent of BMP binding (Oel-
geschlager et al., 2003), as found for CV-2 in this study. A Xeno-748 Developmental Cell 14, 739–750, May 2008 ª2008 Elsevier Inc.pus Tsg protein with a W67G mutation in the N-terminal domain
lost its BMP binding activity but nevertheless ventralized the
embryo effectively, indicating strong pro-BMP activity. Tsg in-
hibits BMP signaling by forming stable ternary complexes with
BMP and Chordin. Concurrently, Tsg facilitates Chordin cleav-
age by the Tolloid protease, resulting in a release of BMP and
stimulation of BMP signaling (pro-BMP) (De Robertis and Kur-
oda, 2004). The Tsg protein shares limited homology with VWC
domains. Unlike most of the VWCs, it binds to the wrist epitope
of BMP-2 and does not block type II receptor binding. However,
the functional similarities between Tsg and CV-2 are striking.
Future experiments will establish whether some parts of CV-2,
Developmental Cell
Crystal Structure of the CV-2 VWC1:BMP-2 Complexsimilar to Tsg, bind Chordin or other Chordin-like proteins. Thus,
a bifunctional CV-2 on one hand directly binds BMP-2 via its
VWC1 domain and thereby might exert anti-BMP functions,
and on the other hand it possibly binds BMPs indirectly via asso-
ciated Chordin proteins and in this way acquires a pro-BMP
activity.
EXPERIMENTAL PROCEDURES
Production of CV2-VWC1 and BMP-2
The CV-2 VWC1 comprising residues Leu1–Gly66 of mature zebrafish CV2
(SWISS-Prot entry Q5D734) plus an N-terminal GSW extension was expressed
in E. coli as a thioredoxin fusion protein and purified as described for BMPR-
IAECD (Kirsch et al., 2000b). The additional Trp residue was introduced to mon-
itor the protein during purification, but it had no influence on binding of CV-2 to
BMP-2 (Table 1). Single amino acid variants of CV-2 VWC1 were obtained by
site-directed mutagenesis. To facilitate X-ray data analysis, a Seleno-methio-
nine derivative of BMP-2 (BMP-2 double variant Y41M/F91M) was generated
by expressing the protein using M9 minimal medium supplemented with 50 mg
l1 DL-SeMet (Acros). BMP-2 was obtained as described (Kirsch et al., 2000a).
Complex Formation and Crystallization
The binary complex of BMP-2 and CV-2 VWC1 was formed by mixing BMP-2
with VWC1 protein in a 1:2.4 molar ratio in 10 mM HEPES (pH 7.4), 700 mM
NaCl. The complex was then purified by gel filtration using a HR10/30 Super-
dex 200 column (GE Healthcare). The fractions were pooled, and the protein
complex was concentrated to 8 mg ml1. Large single crystals grew from
2.2 M ammonium phosphate, 0.1 M Tris (pH 7.5), 8% glycerol, 5% sucrose
at 21C within 2 weeks using the hanging drop vapor diffusion methodology.
Data Acquisition and Structure Analysis
A MAD data set of the binary complex of SeMet-labeled BMP-2 (F41M/
Y91M):CV-2 VWC1 was acquired at three wavelengths with 90 rotation of
the crystal (1 per frame); a maximum resolution of 2.7 A˚ was obtained by re-
cording with a 3 s exposure per degree (beamline BL14.2 BESSY, Germany).
Data were processed using HKL2000 and Scalepack (HKL Research) (Table
2). The positions of the Seleno-sites were determined using SHELX, and re-
fined using SOLVE. RESOLVE was used to automatically trace the electron
density. The structure of the BMP-2 dimer was superimposed onto the tracing
model to facilitate refinement of the complex, which was then performed by
iterative rounds of manual model building using Quanta2006 (Accelrys) and
energy minimizations using Refmac5.2. The final model exhibits R factors of
0.203 (for Rcryst) and 0.245 (for Rfree) and contains 47 water molecules.
Biosensor Interaction Analysis
The binding of CV-2 VWC1 to immobilized BMP-2 resulting in a ‘‘1:1’’ low-af-
finity interaction mode was analyzed using a BIAcore2000 system (Amersham
Biosciences) as described (Zhang et al., 2007). KD values or rate constants koff,
kon were evaluated from one experiment using six to nine different analyte con-
centrations ranging from 10 to 1000 nM. Mean values of KD and their standard
deviations (SD) were calculated from the values of at least three different
experiments. SD values for the obtained affinities were less than 50%.
Biological Activity in Cell Lines
Alkaline phosphatase (ALP) activity was determined in serum-starved C2C12
cells as described (Kirsch et al., 2000a). Inhibition of BMP-2-induced ALP ac-
tivity by modulators was assessed by incubating C2C12 cells with different
concentrations of modulators plus 10 nM BMP-2. Results are given as mean
values from three determinations done in parallel for each condition. The
mRNA injection experiments in zebrafish embryos were done as described
(Hammerschmidt et al., 1999).
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